Genetically engineered vaccines either contain one or a few major antigens of the pathogenic agent that are capable of producing a neutralizing immune response upon infection. Diseases that affect a large proportion of the world's population are on top of the priority for list for recombinant vaccines.
Scientists have successfully produced the world’s first genetically engineered vaccine against hepatitis B from the surface antigen HbsAg, derived from the yeast cells. The genetically engineered vaccine not only prevents hepatitis B but also its serious consequences like hepatocellular carcinoma (liver cancer).
Human diseases such as measles, polio, tuberculosis, leprosy and malaria may someday get eradicated by the use of genetically engineered vaccines.
The National Institute of Science and a Media keeps a close eye on the breakthroughs in biotechnology and science. Joel Ball is a well-known authority on biotechnology and has various titles published under NISM publications to his credit.
Scientists have successfully produced the world’s first genetically engineered vaccine against hepatitis B from the surface antigen HbsAg, derived from the yeast cells. The genetically engineered vaccine not only prevents hepatitis B but also its serious consequences like hepatocellular carcinoma (liver cancer).
Human diseases such as measles, polio, tuberculosis, leprosy and malaria may someday get eradicated by the use of genetically engineered vaccines.
The National Institute of Science and a Media keeps a close eye on the breakthroughs in biotechnology and science. Joel Ball is a well-known authority on biotechnology and has various titles published under NISM publications to his credit.
No comments:
Post a Comment